Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccine (Split Virion), Inactivated (Quadrivalent) 2-dose Regimen in Chinese Children 3–8 Years
CTR20211906Phase 4Completed
- Sponsor
- Changchun Institute of Biological Products Co., Ltd.
- Start
- Aug 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of quadrivalent split virion influenza vaccine in influenza, sponsored by Changchun Institute of Biological Products Co., Ltd.. Started Aug 2021; status: completed.
02
Drugs
quadrivalent split virion influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20211906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211906.